Vyne Therapeutics Inc
NASDAQ:VYNE
Vyne Therapeutics Inc
NASDAQ:VYNE
Price:
0.656
USD
2.34%
Market Cap:
$21.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vyne Therapeutics Inc
NASDAQ:VYNE
|
US |
|
N
|
Northrop Grumman Corp
XMUN:NTH
|
US |
Wall St Price Targets
VYNE Price Targets Summary
Vyne Therapeutics Inc
Vyne Therapeutics Inc
Wall Street analysts forecast VYNE stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for VYNE is 3.315 USD with a low forecast of 2.02 USD and a high forecast of 4.725 USD.
Lowest Forecast
Price Target
2.02
USD
208% Upside
Average Forecast
Price Target
3.315
USD
405% Upside
Highest Forecast
Price Target
4.725
USD
620% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VYNE's stock price target?
Price Target
3.315
USD
3.315
USD
According to Wall Street analysts, the average 1-year price target for VYNE is 3.315 USD with a low forecast of 2.02 USD and a high forecast of 4.725 USD.
What is the Revenue forecast for Vyne Therapeutics Inc?
Projected CAGR
112%
112%
Over the last 9 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 112%.
